摘要
Indoleamine 2,3 dioxygenase 1 (IDO1) is an attractive target for cancer immunotherapy. However, IDO1 inhibitors have shown disappointing therapeutic efficacy in clinical trials, mainly because of the activation of the aryl hydrocarbon receptor (AhR). Here, we show a post-transcriptional regulatory mechanism of IDO1 regulated by a proteasome-associated deubiquitinating enzyme, USP14, in colorectal cancer (CRC). Overexpression of USP14 promotes tryptophan metabolism and T-cell dysfunction by stabilizing the IDO1 protein. Knockdown of USP14 or pharmacological targeting of USP14 decreases IDO1 expression, reverses suppression of cytotoxic T cells, and increases responsiveness to anti-PD-1 in a MC38 syngeneic mouse model. Importantly, suppression of USP14 has no effects on AhR activation induced by the IDO1 inhibitor. These findings highlight a relevant role of USP14 in post-translational regulation of IDO1 and in the suppression of antitumor immunity, suggesting that inhibition of USP14 may represent a promising strategy for CRC immunotherapy.
学科与关键词
- USP12 positively regulates M-MDSC function to inhibit antitumour immunity through deubiquitinating and stabilizing p65Zhan, Xiaoxia; He, Qiuying; Sheng, Junli; Jiang, Xiaobing; Lin, Letao; Huang, Yulan; He, Shitong; Chen, Yitian; Li, Laisheng; Zeng, Zhijie; Hu, Shengfeng*; Wang, Peng*; Zhang, Yanling*Immunology, 2022, 167(4): 544-557.被引 6
- Tryptophan and indole metabolism in immune regulation.Fiore, Alessandra; Murray, Peter J*Current Opinion in Immunology, 2021, 70: 7-14.
- Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer managementLiao, Yihao; Zhou, Diansheng; Wang, Pu; Yang, Mengyue; Jiang, Ning*Cell Death Discovery, 2022, 8(1): 292.被引 6
